{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:36:32Z","timestamp":1769603792113,"version":"3.49.0"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,8]],"date-time":"2013-01-08T00:00:00Z","timestamp":1357603200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053766","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T05:49:56Z","timestamp":1357710596000},"page":"e53766","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Vorinostat Induces Apoptosis and Differentiation in Myeloid Malignancies: Genetic and Molecular Mechanisms"],"prefix":"10.1371","volume":"8","author":[{"given":"Gabriela","family":"Silva","sequence":"first","affiliation":[]},{"given":"Bruno A.","family":"Cardoso","sequence":"additional","affiliation":[]},{"given":"H\u00e9lio","family":"Belo","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio Medina","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2013,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.cell.2008.01.025","article-title":"Hematopoiesis: an evolving paradigm for stem cell biology","volume":"132","author":"SH Orkin","year":"2008","journal-title":"Cell"},{"key":"ref2","first-page":"214143","article-title":"Stintzing S, Kemmerling R, Kiesslich T, Alinger B, Ocker M, et al. Myelodysplastic syndrome and histone deacetylase inhibitors: \u201cto be or not to be acetylated\u201d?","volume":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1053\/j.seminoncol.2008.04.008","article-title":"Epigenetics in acute myeloid leukemia","volume":"35","author":"C Plass","year":"2008","journal-title":"Semin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.pharmthera.2009.03.001","article-title":"Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy","volume":"122","author":"AS Tsiftsoglou","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.seminhematol.2007.11.007","article-title":"DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes","volume":"45","author":"EA Griffiths","year":"2008","journal-title":"Semin Hematol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1182\/blood-2009-01-200519","article-title":"MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation","volume":"114","author":"ME Figueroa","year":"2009","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood.V100.10.3553","article-title":"Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow","volume":"100","author":"WK Hofmann","year":"2002","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/10245330500065680","article-title":"Gene expression profiling in the myelodysplastic syndromes","volume":"10","author":"A Pellagatti","year":"2005","journal-title":"Hematology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2008.10.006","article-title":"Epigenetic therapy of leukemia: An update","volume":"41","author":"N Jain","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-8722-2-31","article-title":"Vorinostat in solid and hematologic malignancies","volume":"2","author":"D Siegel","year":"2009","journal-title":"J Hematol Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1073\/pnas.2536759100","article-title":"Transcriptional signature of histone deacetylase inhibition in multiple myeloma: biological and clinical implications","volume":"101","author":"CS Mitsiades","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.onc.1210204","article-title":"Discovery and development of SAHA as an anticancer agent","volume":"26","author":"PA Marks","year":"2007","journal-title":"Oncogene"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2007-06-098061","article-title":"Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes","volume":"111","author":"G Garcia-Manero","year":"2008","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"BS Mann","year":"2007","journal-title":"Oncologist"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.canlet.2009.01.002","article-title":"Development of vorinostat: current applications and future perspectives for cancer therapy","volume":"280","author":"VM Richon","year":"2009","journal-title":"Cancer Lett"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"14639","DOI":"10.1073\/pnas.1008522107","article-title":"Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair","volume":"107","author":"JH Lee","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e20987","DOI":"10.1371\/journal.pone.0020987","article-title":"Vorinostat induces reactive oxygen species and DNA damage in acute myeloid leukemia cells","volume":"6","author":"LA Petruccelli","year":"2011","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1091\/mbc.E08-02-0139","article-title":"HDAC4 promotes growth of colon cancer cells via repression of p21","volume":"19","author":"AJ Wilson","year":"2008","journal-title":"Mol Biol Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1476-4598-9-275","article-title":"Sp1 acetylation is associated with loss of DNA binding at promoters associated with cell cycle arrest and cell death in a colon cell line","volume":"9","author":"JS Waby","year":"2010","journal-title":"Mol Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/1476-4598-9-276","article-title":"Butyrate suppresses expression of neuropilin I in colorectal cell lines through inhibition of Sp1 transactivation","volume":"9","author":"DC Yu","year":"2010","journal-title":"Mol Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e18087","DOI":"10.1371\/journal.pone.0018087","article-title":"HDAC inhibition decreases the expression of EGFR in colorectal cancer cells","volume":"6","author":"CW Chou","year":"2011","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJMoa063369","article-title":"Targeted therapy for inherited GPI deficiency","volume":"356","author":"AM Almeida","year":"2007","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm1410","article-title":"Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency","volume":"12","author":"AM Almeida","year":"2006","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1091\/mbc.E05-08-0775","article-title":"Regulation of histone deacetylase 4 expression by the SP family of transcription factors","volume":"17","author":"F Liu","year":"2006","journal-title":"Mol Biol Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"17785","DOI":"10.1074\/jbc.M209430200","article-title":"Sp family of transcription factors is involved in valproic acid-induced expression of Galphai2","volume":"278","author":"IJ Arinze","year":"2003","journal-title":"J Biol Chem"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.aanat.2010.07.010","article-title":"The role of Sp1 and Sp3 in normal and cancer cell biology","volume":"192","author":"L Li","year":"2010","journal-title":"Ann Anat"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/10428190500264231","article-title":"DNA micro-array analysis of myelodysplastic syndrome","volume":"47","author":"H Mano","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","article-title":"Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype","volume":"108","author":"A Pellagatti","year":"2006","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1365-2141.2004.04958.x","article-title":"Gene expression profiling in the myelodysplastic syndromes using cDNA microarray technology","volume":"125","author":"A Pellagatti","year":"2004","journal-title":"Br J Haematol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/10428199709042499","article-title":"Recent progress on the role of Axl, a receptor tyrosine kinase, in malignant transformation of myeloid leukemias","volume":"25","author":"A Neubauer","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.4049\/jimmunol.177.3.1894","article-title":"The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform","volume":"177","author":"G Silva","year":"2006","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"29582","DOI":"10.1074\/jbc.M109.045344","article-title":"Oxidized hemoglobin is an endogenous proinflammatory agonist that targets vascular endothelial cells","volume":"284","author":"G Silva","year":"2009","journal-title":"J Biol Chem"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1309\/AJCPCRK3MOAOJ6AT","article-title":"CD71 (transferrin receptor): an effective marker for erythroid precursors in bone marrow biopsy specimens","volume":"134","author":"DK Marsee","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cyto.b.20513","article-title":"Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients","volume":"78","author":"S Matarraz","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"25466","DOI":"10.1074\/jbc.273.39.25466","article-title":"Heat shock factor 1 mediates hemin-induced hsp70 gene transcription in K562 erythroleukemia cells","volume":"273","author":"T Yoshima","year":"1998","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1073\/pnas.75.5.2458","article-title":"Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds","volume":"75","author":"SJ Collins","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.2910260208","article-title":"Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)","volume":"26","author":"S Tsuchiya","year":"1980","journal-title":"Int J Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1158\/1541-7786.MCR-09-0326","article-title":"Myeloid zinc finger 1 induces migration, invasion, and in vivo metastasis through Axl gene expression in solid cancer","volume":"8","author":"G Mudduluru","year":"2010","journal-title":"Mol Cancer Res"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/1947601910377495","article-title":"Myc roles in hematopoiesis and leukemia","volume":"1","author":"MD Delgado","year":"2010","journal-title":"Genes Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4161\/epi.5.7.12558","article-title":"Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia","volume":"5","author":"EA Griffiths","year":"2010","journal-title":"Epigenetics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1590\/S1415-47572008000400005","article-title":"DNA methylation analysis of the tumor suppressor gene CDKN2B in Brazilian leukemia patients","volume":"31","author":"PSP Lima","year":"2008","journal-title":"Genetics and Molecular Biology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1349-7006.2009.01413.x","article-title":"Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia","volume":"101","author":"V Martin","year":"2009","journal-title":"Cancer Sci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"D Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3844\/ajbbsp.2006.33.40","article-title":"The Biology of p21Waf1\/Cip1 - Review Paper","volume":"2","author":"RA Blundell","year":"2006","journal-title":"American Journal of Biochemistry and Biotechnology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jmcb\/mjq039","article-title":"The role of RAD9 in tumorigenesis","volume":"3","author":"HB Lieberman","year":"2011","journal-title":"J Mol Cell Biol"},{"key":"ref46","first-page":"607","article-title":"Dose-dependent expression changes of early response genes to ionizing radiation in human lymphoblastoid cells","volume":"19","author":"XH Long","year":"2007","journal-title":"Int J Mol Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1242\/jcs.030197","article-title":"Semaphorin signaling in cancer cells and in cells of the tumor microenvironment\u2013two sides of a coin","volume":"122","author":"L Capparuccia","year":"2009","journal-title":"J Cell Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1200\/JCO.2005.14.167","article-title":"Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer","volume":"23","author":"WK Kelly","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref49","first-page":"4878","article-title":"Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A. Cancer Res","volume":"67","author":"Z Jia","year":"2007"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1523\/JNEUROSCI.0710-11.2011","article-title":"Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration","volume":"31","author":"SF Sleiman","year":"2011","journal-title":"J Neurosci"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/cdd.2010.110","article-title":"The Notch2-Jagged1 interaction mediates stem cell factor signaling in erythropoiesis","volume":"18","author":"A Zeuner","year":"2011","journal-title":"Cell Death Differ"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000093022","article-title":"Elevated serum soluble CD30 precedes the development of AIDS-associated non-Hodgkin\u2019s B cell lymphoma","volume":"27","author":"EC Breen","year":"2006","journal-title":"Tumour Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2009-12-258913","article-title":"Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation","volume":"116","author":"K Friedbichler","year":"2010","journal-title":"Blood"},{"key":"ref54","first-page":"1299","article-title":"Inhibition of NF-kappaB and Akt pathways by an antibody-avidin fusion protein sensitizes malignant B-cells to cisplatin-induced apoptosis","volume":"36","author":"E Suzuki","year":"2010","journal-title":"Int J Oncol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/sj.onc.1209236","article-title":"ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia","volume":"25","author":"X Agirre","year":"2006","journal-title":"Oncogene"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1182\/blood-2002-08-2617","article-title":"Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin","volume":"101","author":"O Witt","year":"2003","journal-title":"Blood"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","article-title":"Histone deacetylases and cancer","volume":"26","author":"MA Glozak","year":"2007","journal-title":"Oncogene"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.leukres.2007.03.012","article-title":"Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia","volume":"31","author":"YC Cheng","year":"2007","journal-title":"Leuk Res"},{"key":"ref59","first-page":"42084","article-title":"Activation of p21(WAF1\/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C. J Biol Chem","volume":"276","author":"JW Han","year":"2001"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"26725","DOI":"10.1074\/jbc.M702885200","article-title":"v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex","volume":"282","author":"Y Bu","year":"2007","journal-title":"J Biol Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1074\/jbc.M109.062430","article-title":"Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex","volume":"285","author":"A Suzuki","year":"2010","journal-title":"J Biol Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"16272","DOI":"10.1074\/jbc.M513405200","article-title":"Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter","volume":"281","author":"F Stossi","year":"2006","journal-title":"J Biol Chem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1111\/j.1365-2443.2007.01104.x","article-title":"The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression","volume":"12","author":"Y Wu","year":"2007","journal-title":"Genes Cells"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T13:44:45Z","timestamp":1714830285000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053766"}},"subtitle":[],"editor":[{"given":"Arun","family":"Rishi","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2013,1,8]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053766","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,8]]}}}